Commission Actions

The Hatch-Waxman Act, passed by Congress more than 30 years ago, provides a regulatory and judicial framework to expedite generic entry into U.S. prescription drug markets. For many drugs, the Act has...

FTC Administrative Law Judge Michael D Chappell will hear the matter of Impax, Docket No. 9373. FTC Headquarters, 600 Pennsylvania Ave. NW, Room 532, Washington, DC

FTC Acting Chairman Maureen K. Ohlhausen will deliver keynote remarks at the FTC Workshop, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” Constitution...

On November 7, 2017, the Federal Trade Commission’s Economic Liberty Task Force hosted a roundtable to examine empirical evidence on the effects of occupational licensure.Licensing restrictions –...

FTC Commissioner Terrell McSweeny will participate in a debate at the Web Summit Conference on – “We should be prepared to give up our privacy for security.” Lisbon, Portugal, 11:55am GMT

FTC Acting Chairman Maureen K. Ohlhausen will deliver opening remarks at the FTC Economic Liberty Task Force’s second public roundtable, “The Effects of Occupational Licensure on Competition...

FTC Administrative Law Judge Michael D Chappell will hear the matter of Impax, Docket No. 9373. FTC Headquarters, 600 Pennsylvania Ave. NW, Room 532, Washington, DC